Build Your Own Application With Coghead

I have been invited to participate in Coghead beta program. Coghead's catch line is a:

Simple, powerful new way to create web-based business applications that can be used by anyone, anytime, anywhere!

Their application is built using OpenLaszlo and provides a very responsive user experience. I have been evaluating their application and they definitely get the idea right. End users have a multitude of needs for business application. We could refer to this as the long tail of business applications. And IT cannot respond to everyone of those needs in a scalable manner. Therefore it makes sense to create an application that empowers business users to quickly create applications as their needs occur. Coghead Gallery provides a number of application templates to quickly get started.


Where I personally find that Coghead falls short is with its concept of collection Coghead allows users to build applications made collections, forms, views, and actions. Collections are objects used by the application. They contain records. A collection describes a data structure, and provides tools for viewing and modifying data of that type. Records are the actual data that is stored; each record is an instance of the data defined by the Collection. For example, if you have a collection “Purchase Orders” then a record would be the data that makes up one purchase order.

Though a powerful concept, it does not go far enough in my opinion. Business application needs go beyond the need to assemble collections. Nevertheless, this is a good start and a nice application.

The New Era of The Long Tail of the Pharmaceutical Industry?

I came across a good article on the New York Times this morning, The Dangers of Swinging for the Fences by Joe Nocera. Reading this article, I could not help but think whether the pharmaceutical industry had entered a new era where addressing the long tail of drugs production would be the next evolution for that industry.

Joe Nocera makes the point in his article that the pharmaceutical business is changing. This is particularly well illustrated by the tough times at Pfizer. The modern Pfizer was built on Blockbusters, which is what the industry calls medicines that generate $1 billion or more in annual revenue.

At Pfizer for instance, the top 4 drugs account for 35% of revenue. Lipitor alone with $12.9 billion in annual revenue accounts for 27% of Pfizer's revenue. And with Lipitor coming off patent in 2010, Pfizer needs to worry on how to make up for that blockbuster's revenue.

The blockbuster business model is falling apart - and not only in the pharmaceutical industry by the way. First, big bets like the Lipitor one, require a significant time period to recover the investments to produce such blockbuster and drug patents expire after 17 years. Second, expensive go to market strategies with direct advertising to consumer and doctors are experiencing a backlash.

New business models in the pharmaceutical industry are starting to favor the long tail of drugs where new discoveries tend to be very much targeted and according to Harvard economist David Cutler:

Drugs are eventually going to be customized for individuals.

Jeffrey Kindler, CEO of Pfizer is betting on it and wants Pfizer to become as good at developing $500 million drugs as in coming up with new blockbusters. Well, that's a big bet for Pfizer and let's hope with Pfizer can pull it off.

It will make for a much healthier industry and could be the start of a new area of the long tail of the pharmaceutical industry. It will be interesting to watch closely how successful Pfizer is at revolutionizing its industry.

What do the "Out There" People in Your Organization Think?

The Attention Company posted an interesting survey on what it calls the "Out There" people. See the "Out There" survey and the "Out There" reactions.

In a nutshell, the survey makes the following points as described below:

• The "Out There" people are the ones "participating in online communities"
  • 20% of your organization population very active
  • 32% are somehow active
• They are the winners in your organization
• Information is everything:
  • Employees at the bottom levels of an organization have most of the knowledge
  • Transparency in decision making increases the likelihood of success

These points are particularly interesting when put in context with organizations and how better information sharing techniques can help organization perform better. This shows the benefits of having a strategy to best disseminate information and knowledge within a company.